據報內地監管對大行理財產品9月起所配資產不得採用成本法估值
據《證券時報》報道,內地監管對六家國有大行及其理財公司做出指導,並進行兩項重要安排。其一,於過渡期結束後(2021年末),不得再存續或新發以攤餘成本計量的定期開放式理財產品;其二,除嚴格按照現行監管規定使用攤餘成本計量外,理財產品(除現金管理產品)自9月起新增的直接和間接投資的資產,均應優先使用市值法進行公允價值計量,暫不允許對除未上市企業股權外的資產採用成本法估值。
已適用成本法估值的理財產品存量資產,應於今年10月底前完成整改。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.